Cascadian Therapeutics has been acquired by Seattle Genetics, Inc.

The investigational pipeline product, tucatinib, can be found at
http://www.seattlegenetics.com/pipeline/tucatinib

If you are not automatically redirected to the Seattle Genetics website, please click here.